MedTrace Logo

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

NCT05786131 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3390

Last updated 2025-01-16

No results posted yet for this study

Summary

Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.

Conditions

  • Non-ST-elevation Myocardial Infarction
  • Multivessel Coronary Artery Disease

Interventions

PROCEDURE

Culprit-lesion revascularization

Percutaneous coronary intervention of culprit-lesion

PROCEDURE

Non-culprit-lesion revascularization

Complete percutaneous coronary intervention of all angiographically significant non-culprit lesions

Sponsors & Collaborators

  • Heart Center Leipzig at University of Leipzig

    collaborator UNKNOWN

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • IHF GmbH - Institut für Herzinfarktforschung

    collaborator OTHER

  • Stiftung IHF - Institut für Herzinfarktforschung

    collaborator UNKNOWN

  • Leipzig Heart Science gGmbH

    lead OTHER

Principal Investigators

  • Holger Thiele, MD, Prof. Dr. · Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2027-01-31
Completion
2027-07-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05786131 on ClinicalTrials.gov